#GenomicNewbornScreening
Newborn screening has transformed child health, but expanding screening panels will require strong evidence, sustained policy support, and continued investment in rare disease research. bit.ly/3UVCxFq #GIMO #NewbornScreening #GenomicNewbornScreening
September 16, 2026 at 7:57 PM
Public attitudes in Germany toward #genomicnewbornscreening are largely positive despite low prior knowledge—highlighting the importance of improving genetic literacy to support informed acceptance. bit.ly/4ljhFku #GIMO #Advantages #Disadvantages #Knowledge #Uncertainty
March 10, 2026 at 10:10 PM
Excited to share a new D2R-funded project led by Larry Lynd (UBC), co-led by Profs @YannJoly6 & @MHZawati (CGP, McGill): Early assessment of the value of novel #RNAtherapeutics in #genomicnewbornscreening initiatives: health, economic and ethical implications.
🧶
Foundational Projects | Cycle 2
The Foundational Projects funding program supports high-risk, early-stage projects with the potential to be game-changers in the fields of D2R’s areas of interest. In the second funding cycle launched...
www.mcgill.ca
November 7, 2025 at 7:33 PM
New #publication of our #NEW_LIVES project 👶🧬

"Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?"

by Schnabel-Besson et al. @Int. J. Neonatal Screen.

#newbornscreening #NBS #neonatalscreening #genomicnewbornscreening #gNBS

doi.org/10.3390/ijns...
Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?
Driven by technological innovations, newborn screening (NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS ...
doi.org
September 18, 2024 at 10:02 AM